Hematology Consults | An Expanding Clinical Landscape of GVHD – Module 2

Steroid-Refractory Acute and Chronic GVHD

There is little guidance about choosing the most appropriate therapy for patients with graft vs host disease (GVHD) after undergoing an allogeneic hematopoietic stem cell transplantation (alloHSCT). Until the recently, steroids were the only agents with proven ability to treat patients with GVHD. However, GVHD often becomes steroid resistant or refractory. In response to this problem, the Janus kinase (JAK) inhibitor, ruxolitinib, and the Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib, were studied, then approved as second-line treatments. A large number of other agents are also available to treat patients with GVHD, though all of these agents have relatively weak efficacy. The choice of therapy is often dictated by personal and institutional experience and patient-specific comorbidities and tolerance. Using patient cases, this activity reviews the safety and efficacy of emerging agents for the management of patients with GVHD and illustrates appropriate therapy selection for patients experiencing steroid-refractory acute and chronic GVHD.

Additional information
Contact email: 
cmenet@jhmi.edu
Course summary
Available credit: 
  • 0.50 ANCC
Registration opens: 
12/28/2020
Registration closes: 
12/28/2021
Cost:
$0.00

Hematology Consults.com is a real-world focused, interactive, case-based, e-learning platform. Here, you will find interactive, written, enduring, Continuing Education (CE) modules accredited by the Institute for Johns Hopkins Nursing, developed and executed with clinical oversight by top experts in many hematology specialties. Activities are available on a wide range of topics, and allow participants the opportunity to apply the information learned in day-to-day patient care.

Jonathan Moreira, MD
Assistant Professor of Medicine
Robert H. Lurie Comprehensive Cancer Center
Department of Medicine, Division of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

  • Accreditation Statement:  The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
  • ​Statement of Contact Hours:  This 0.5 contact hour educational activity is provided by The Institute for Johns Hopkins Nursing. The 0.5 contact hours will be awarded from the Hematology Consults website after the completion.
  • Conflict of Interest:  It is the policy of The Institute for Johns Hopkins Nursing to require our continuing nursing education program faculty and planning committee members to disclose any financial relationships with companies providing program funding or manufacturers of any commercial products discussed in the program.  The planning committee and program faculty report that they do not have financial relationships with manufacturers of any commercial products they discuss in the program.
  • Commercial Support:  This educational activity has not received any form of commercial support.
  • Non-Endorsement of Products:  The Institute for Johns Hopkins Nursing and the American Nurses Credentialing Center does not endorse the use of any commercial products discussed or displayed in conjunction with this educational activity.

Available Credit

  • 0.50 ANCC

Price

Cost:
$0.00
Please login or register to take this course.

You will be redirected to the Hematology Consults website.

If you do not have an account on their website you will need to create an account before logging in to access this free course.

Click HERE to be directed to the Hematology Consults website. Select the desired article and proceed as instructed on the site. A certificate of participation will be available online immediately following successful completion of the activity.